QH-II-66

QH-II-66 is a drug that belongs to the benzodiazepine class of medications. It is a sedative and anxiolytic drug that was developed by the China-based company, Qihuang Pharmaceutical.

History

QH-II-66 was first synthesized in the late 20th century by Qihuang Pharmaceutical. The drug was developed as part of a larger effort to create new benzodiazepine derivatives with improved therapeutic properties.

Pharmacology

Like other benzodiazepines, QH-II-66 works by enhancing the effect of the neurotransmitter gamma-aminobutyric acid (GABA) at the GABAA receptor, resulting in sedative, sleep-inducing (hypnotic), anxiolytic (anti-anxiety), anticonvulsant, and muscle relaxant properties.

Medical Uses

QH-II-66 is primarily used for the treatment of anxiety disorders, insomnia, and seizure disorders. It may also be used as a premedication for medical or dental procedures.

Side Effects

Common side effects of QH-II-66 include drowsiness, dizziness, and loss of coordination. More serious side effects may include memory problems, depression, and addiction.

See Also

• Benzodiazepine
• GABAA receptor
• Anxiety disorder
• Insomnia
• Seizure disorder

This article is a medical stub. You can help WikiMD by expanding it!
Most recent articles Ongoing trials	Wikipedia